原文开头
LSD could be approved for treating anxiety in the US as soon as 2027. This expectation comes after a landmark trial showed that a single dose of the psychedelic drug eased the mental health condition without severe or lasting side effects. “It’s a milestone,” says Greg Cooper at University College London, who wasn’t involved in the trial. “It looks fairly likely that approval from the [US Food and Drug Administration] will happen in the next year or two,” he says. “That would set a precedent for approval elsewhere, such as the UK and Europe.” The trial was made up of people with moderate or severe anxiety who had tried a range of standard therapies. …
摘自《新科学家》(New Scientist)2026年9月26日,Carissa Wong。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。